CGEM Competitors & Alternatives
Compare Cullinan Oncology LLC with similar stocks in the same industry
Biotechnology
CGEM
Main Stock$17.87
Tradestie Score
61
Market Cap
$354.45M
Analyst Upside
+76.5%
Top Competitors
231 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ELVN
Enliven Therapeutics, Inc. Common Stock
|
$50.87
|
$1.17B | - | 63 | Compare |
|
INVA
Innoviva, Inc. Common Stock
|
$22.21
|
$1.15B | 3.6 | 63 | Compare |
|
TRVI
Trevi Therapeutics, Inc. Common Stock
|
$16.52
|
$1.14B | - | 53 | Compare |
|
ORIC
Oric Pharmaceuticals, Inc. Common Stock
|
$10.46
|
$1.14B | - | 63 | Compare |
|
MAZE
Maze Therapeutics, Inc. Common Stock
|
$29.18
|
$1.13B | - | 62 | Compare |
|
WVE
Wave Life Sciences Ltd. Ordinary Shares
|
$5.95
|
$1.12B | - | 59 | Compare |
|
NKTR
Nektar Therapeutics
|
$68.32
|
$1.12B | - | 59 | Compare |
|
PRAX
Praxis Precision Medicines, Inc. Common Stock
|
$314.56
|
$1.12B | - | 60 | Compare |
|
IMTX
Immatics N.V. Ordinary Shares
|
$9.23
|
$1.09B | - | 56 | Compare |
|
PHAR
Pharming Group N.V. ADS, each representing 10 ordinary shares
|
$13.77
|
$1.05B | 72.9 | 60 | Compare |
More CGEM Analysis
Data updated: Jul 13, 2026 | Industry: Biotechnology (SIC 2836)
231 stocks in this industry